Sign In
Buy MACK
$15.13
+0 (+0%)
At Close: Aug 19, 2024
Mackay Gold & Silver Announces Listing on the OTCQB Under the Symbol "MKGSF"
08:00am, Friday, 22'nd May 2026
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2026) - Mackay Gold & Silver Corp. (TSXV: MACK) (OTCQB: MKGSF) ("Mackay" or the "Company") is pleased to announce that its common shares have com
Arthur J. Gallagher & Co. Acquires MACK Insurance Services
10:00am, Tuesday, 05'th Aug 2025
ROLLING MEADOWS, Ill. , Aug. 5, 2025 /PRNewswire/ -- Arthur J.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) announced that the stockholders at a Special Meeting held today overwhelmingly
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that it has filed notice with NASDAQ of the Company's intent to
Merrimack Receives $225 Million Milestone Payment from Ipsen
04:30pm, Wednesday, 27'th Mar 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that it has received a $225 million payment which was due from
Merrimack Reports Full Year 2023 Financial Results
04:30pm, Thursday, 07'th Mar 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Reports Full Year 2023 Financial Results.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) reported that Ipsen, SA (“Ipsen”) issued a press release today announcing t
Merrimack Reports Third Quarter 2023 Financial Results
04:30pm, Thursday, 02'nd Nov 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Reports Third Quarter 2023 Financial Results.
Merrimack Reports Second Quarter 2023 Financial Results
04:30pm, Thursday, 03'rd Aug 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Reports Second Quarter 2023 Financial Results.
Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments
04:08pm, Friday, 12'th May 2023
BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-t
Virpax Pharmaceuticals To Present at Upcoming CB Tech Watch Seminar
07:15am, Wednesday, 10'th May 2023
BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-t
Nuss Truck & Equipment Launches e-Emphasys Dealer Management Platform
08:00am, Tuesday, 09'th May 2023
CARY, N.C.--(BUSINESS WIRE)--e-Emphasys Technologies Inc., a global enterprise software provider for the heavy equipment and industrial machinery industry, today announced that Nuss Truck & Equipment,
Seven Neal Gerber Eisenberg Attorneys Recognized for Excellence in Pro Bono Service
10:10am, Friday, 05'th May 2023
CHICAGO--(BUSINESS WIRE)--Neal Gerber Eisenberg (NGE) is pleased to announce that seven of its attorneys have received the 2023 Award for Excellence in Pro Bono Service from the U.S. District Court fo
Merrimack Reports First Quarter 2023 Financial Results
05:00pm, Thursday, 04'th May 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its first quarter 2023 financial results for the period ended
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference May 10-11, 2023
08:58am, Thursday, 04'th May 2023
BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-t
